VIENNA, July 20 Following significant advances in vaccine and microbicide research, including results presented today of 39% efficacy in the CAPRISA 004 microbicide gel trial among women in South Africa, a new report released today ...
VIENNA, July 20 INTERNATIONAL AIDS CONFERENCE 2010 -- MTV, the U.S. President's Emergency Plan for AIDS Relief (PEPFAR) and UNICEF today unveiled at INTERNATIONAL AIDS CONFERENCE 2010, new research on its Staying Alive Ignite Campaign at, which ...
CAPRISA 004 trial shows moderate protection against transmission of virus JOHANNESBURG and WASHINGTON, July 19 /PRNewswire-USNewswire/ -- Results of an advanced clinical trial of an antiretroviral-based microbicide candidate are being ...
VIENNA, July 19 Today's news of a microbicide that significantly reduced HIV infection is an exciting step forward in the fight against HIV. Equally exciting is the news that the microbicide also reduced the rate of infection of the herpes ...
VIENNA, July 19 Phase II data for TBR-652, a novel compound being developed by Tobira Therapeutics for the treatment of HIV infection, demonstrate that the dual CCR5/CCR2 antagonist provides potent antiviral activity and inhibition of ...
Two-Fold Increase in Risk May Be Directly Linked to HIV WASHINGTON, July 19 /PRNewswire-USNewswire/ -- At the same time that medical science has nearly eliminated AIDS deaths in patients treated for human immunodeficiency virus (HIV), ...
VIENNA, July 19 Phase II data for TBR-652, a novel compound being developed by Tobira Therapeutics for the treatment of HIV infection, demonstrate that the dual CCR5/CCR2 antagonist provides potent antiviral activity and inhibition of ...
In Keynote Speech to AIDS Conference, Gates Outlines Roadmap to Reduce Annual New HIV Infections 90% by 2031 VIENNA, July 19 /PRNewswire-USNewswire/ -- Speaking to the 18th International AIDS Conference today, Bill Gates called on all ...
VIENNA, July 19 Argos Therapeutics today announced that, in an interim analysis of a Phase 2 trial, its Arcelis immunotherapy targeted at HIV, AGS-004, demonstrated a significant reduction in viral load and a delay in viral rebound ...
Thousands of AIDS advocates, legislators, researchers and practitioners gather for the Rights Here, Right Now themed meeting in Vienna VIENNA, July 19 /PRNewswire-USNewswire/ -- Technical staff from PSI (Population Services International), a ...
Eamonn Murphy’s keynote address at the End TB Dialogues Summit highlights the ongoing relevance of integrating TB and HIV services, echoing a call to action initiated by Dr. France almost two decades ago to "break the silos" for improved healthcare ...
Comprehensive treatment for all HIV -positive individuals, effectively suppressing the virus, is pivotal in curbing transmission and steering India towards an end to AIDS. ...
In a monumental leap forward in the battle against HIV/AIDS , researchers at the University of Amsterdam have reported a success in using CRISPR gene-editing technology to eliminate HIV from infected cells. This revolutionary achievement offers a ...
Initiating treatment at an early stage may contribute to sustained control of the HIV virus, provided that the treatment is consistently maintained without interruptions. ( ) People living with HIV need to take antiretroviral treatment for life to prevent the virus from multiplying in their ...
Amsterdam UMC, with the leadership of Rogier Sanders and a grant from the Bill & Melinda Gates Foundation, is at the forefront of a global project to develop a practical HIV vaccine ( ). This would help address the significant ...
Subscribe to our Free Newsletters!
Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment.
Full Disclaimer
Advertise with us | Medindia Copyright | Privacy Policy | Terms of Use © All Rights Reserved 1997 - 2024
Careers